The Health and Economic Impacts of Opportunistic vs Organized Lung Cancer Screening in Canada

The Analytic Capacity Building Initiative at the Canadian Partnership Against Cancer (CPAC) would like to invite you to attend a webinar on “The health and economic impacts of opportunistic vs organized lung cancer screening in Canada” on March 31st 2016 from 12-1 pm EST. The webinar will be presented by Cindy Gauvreau, PhD, Program Manager, Economics & Cancer Risk Management Platform at the Canadian Partnership Against Cancer.

The webinar details including the teleconference and WebEx information is provided below. Please note that pre-registration is not required. You will be able to simply call-in using the teleconference line and attendee access code and sign into the WebEx link provided.

On March 7, 2016 the Canadian Task Force on Preventive Health (CTFPH) recommended lung cancer screening of high risk individuals using low-dose computed tomography (LDCT). The US Preventive Services Task Force had in 2013 issued guidelines for slightly more expansive screening, but nevertheless targeted high risk individuals. These Task Force guidelines balance a demonstrated 20% drop in lung cancer mortality through LDCT screening with the current lack of high quality evidence for efficacy among low-risk individuals and with the potential risks of LDCT screening. In this webinar we will use the Cancer Risk Management Model (CRMM) (version 2.2) to explore the consequences of screening outside the CTFPH guidelines among lower risk individuals in the Canadian context. We will present projected health and economic outcomes of various scenarios of opportunistic screening compared to a scenario of programmatic screening adhering to the CTFPH guidelines. The CRMM is a microsimulation model mimicking individuals’ life course in the context of cancer control interventions, and can be used to help evaluate relevant strategies when it is not possible to do so in real life.